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Abstracts 193research. He co-founded the Molecular Imaging North Competence Center
(MOIN CC) at the Christian-Albrechts-Universita¨t zu Kiel, a preclinical imag-
ing lab. At MOIN CC, multi modal imaging studies combining micro computed
tomography, high-field magnetic resonance imaging, high resolution ultra-
sound, fluorescence and bioluminescence imaging can be carried out to
study morphological, functional, cellular, and molecular processes in health
and disease and to assess therapeutic effects.
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holds 3 patents.OPPORTUNISTIC BONE DENSITY SCREENING BY DUAL-USE OF CT SCANS
Alan Brett, PhD
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Central DXA of the lumbar spine and proximal femur is the preferred method
for bone mineral density (BMD) testing. Despite the fracture risk statistics,
osteoporosis testing with dual energy X-ray absorptiometry (DXA) remains
underused. However, BMD can also be assessed with other radiologic imaging
tools, such as quantitative computed tomography (QCT) that may be
available when access to DXA is restricted.
For patients undergoing screening CT colonography (CTC), a potential
opportunity exists for concurrent BMD screening by QCT without the need
for any additional imaging, radiation exposure, or patient time. In addition,
there are a number of indications for CT imaging for which there is a large
overlap between the need for a CT scan and a patient having risk factors for
osteoporosis. Use may also be made of these CT images for BMD measure-
ment by QCT. Such dual-use of CT images could increase screening rates or,
alternatively, preclude the need for DXA screening in some individuals.
Previous studies combining standard CT imaging and QCT have generally
focused on BMD measurement at the lumbar spine. QCT provides a volumetric
BMD measure of the trabecular vertebral bone in isolation. This can have an
advantage of superior sensitivity due to the higher turnover rate of trabecular
bone, but QCT T-scores are somewhat lower than DXA T-scores for the same
age and the established WHO classification of osteoporosis by DXA T-score is
not appropriate. In contrast, at the proximal femur, QCT 3D data may be used
to derive a projectional 2D image of the proximal femur and this imagemay be
analyzed using standard DXA ROIs to determine DXA-equivalent “CTXA” aBMD
values in g/cm2. Using this method, the WHO T-score classifications may be
applied and the aBMD measures may be included in FRAX calculations.
Theworkflowassociatedwith such dual-use of CTscansmaybe improved by the
use of phantomless or “asynchronous” calibration methods, so that the BMD
measurement does not need to be planned in advance of the CT scan. In
addition, using such methods, it is possible to make use of archived CT scans
retrospectively. Finally, the use of IV contrast-enhanced CT images for QCT is
usually contraindicated and a measurement bias has been shown at the spine.
However, some recent studies suggest that for measurements made at the hip,
themeasurementdifferencedue tocontrast enhancementmaynotbeclinically
significant, further widening the utility of CT scans for BMD measurement.
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QCT is increasingly used for the analysis of clinical studies and of
epidemiology data. To date a number of different software options exist
for the analysis of QCT images. As a consequence, a multitude of parameters
related to bone mineral density, bone geometry and related to bone
strength can be obtained in various volumes of interest in the spine and
proximal femur. Many of them are highly correlated and appropriate analysis
strategies will be discussed. In addition a number of different algorithms
such as global or local adaptive thresholds using different criteria to segment
the cortex are in use to quantify parameters such as cortical BMD, BMC or
thickness. Strengths and weaknesses of the different approaches will be
discussed by comparing effects on accuracy errors of one-time measure-
ments and on accuracy errors of changes during longitudinal measurements.
In contrast to QCT, hr-pQCT measurements of the radius and tibia are more
standardized as only the XtremeCT scanner is available for hr-pQCT
measurements in humans. But also for this scanner different algorithms to
assess the cortex exist and a newer version, which allows for faster scan
times and slightly higher spatial resolution has been introduced recently.
The lecture will review recent use of QCT using whole body CT scanners and
of hr-pQCT to predict or discriminate hip fracture and to monitor age related
changes or treatment efficacy in recent clinical trials in osteoporosis. It will
include a brief introduction to advanced QCT methodology. Learning
objectives are to understand what is measured by QCT, what are the
advantages of QCT and hr-pQCT (in particular compared to DXA) and what
potential pitfalls exist in the interpretation of QCT and hr-pQCT parameters.
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